Cita APA

Favaloro, L., Diez, M., Mendiz, O., Vera Janavel, G., Valdivieso, L., Ratto, R., . . . Crottogini, A. J. (2013). High-Dose Plasmid-Mediated VEGF Gene Transfer is Safe in Patients With Severe Ischemic Heart Disease (GENESIS-I): A Phase I, Open-Label, Two-Year Follow-up Trial. Web

Citación estilo Chicago

Favaloro, Liliana, et al. High-Dose Plasmid-Mediated VEGF Gene Transfer Is Safe in Patients With Severe Ischemic Heart Disease (GENESIS-I): A Phase I, Open-Label, Two-Year Follow-up Trial. 2013.

Cita MLA

Favaloro, Liliana, et al. High-Dose Plasmid-Mediated VEGF Gene Transfer Is Safe in Patients With Severe Ischemic Heart Disease (GENESIS-I): A Phase I, Open-Label, Two-Year Follow-up Trial. 2013.